Group Intervention + CGM for Prediabetes

(CGM Trial)

This trial aims to help individuals with prediabetes prevent or delay type 2 diabetes by combining two approaches: group visits and continuous glucose monitors (CGMs). Group visits offer support and education on healthy eating, exercise, and stress management. CGMs, wearable devices, track blood sugar levels in real-time, illustrating how lifestyle choices impact the body. The study seeks participants diagnosed with prediabetes who can attend group meetings in Conroe, TX, and are comfortable using CGM devices. As an unphased trial, this study provides a unique opportunity to actively engage in innovative research that could enhance health and well-being.

If you are currently taking glucose-lowering medications like GLP-1 or Metformin, you cannot participate in this trial. The protocol does not specify about other medications, so it's best to discuss with the trial team.

Research has shown that Continuous Glucose Monitors (CGMs) are generally safe for individuals with prediabetes. Studies have found that CGM devices help users manage blood sugar more effectively without major side effects. For instance, one study found that CGM users felt more confident in managing their condition and improved their health habits.

Unlike standard treatments for prediabetes, which often rely solely on medication and lifestyle advice, this innovative approach combines group sessions with real-time feedback using Continuous Glucose Monitoring (CGM). Researchers are excited about this treatment because it offers personalized insights into how diet, exercise, stress, and sleep affect blood sugar levels, empowering participants to make informed lifestyle changes. The integration of group support and expert guidance from nutritionists, exercise specialists, and behavioral health clinicians enhances motivation and accountability, potentially leading to more sustainable health improvements.

Research has shown that using Continuous Glucose Monitors (CGMs) along with group sessions can benefit people with prediabetes. In this trial, participants will receive a combination of group sessions and CGM-based behavioral feedback. CGMs track blood sugar levels in real-time, allowing individuals to see how their eating and activity affect their bodies. This understanding can lead to better blood sugar control. For instance, one study found that using a CGM led to a noticeable drop in HbA1c, which measures average blood sugar levels, by about 0.4%. Group sessions provide support and teach healthy habits, further improving results. Together, these tools encourage healthier lifestyles and help prevent the development of type 2 diabetes.¹⁵⁶⁷⁸